Onco-NX Overview

  • Founded
  • 2011
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Onco-NX General Information


Operator of a drug development company. The company engages in the development of drugs and medicines to detect cancerous tumour cells.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • Faraday House
  • 43 Crescent
  • Salford M5 4WT
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Onco-NX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 11-Mar-2014 000.00 Completed Startup
1. Early Stage VC 09-Nov-2011 000.00 000.00 Completed Startup
To view Onco-NX’s complete valuation and funding history, request access »

Onco-NX Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Spark Impact Corporate Venture Capital Minority 000 0000 000000 0
To view Onco-NX’s complete investors history, request access »